https://www.selleckchem.com/pr....oducts/epacadostat-i
The objective of this study was to identify clinical and laboratory risk factors for ischemic stroke (IS) in primary antiphospholipid syndrome (APS) patients. We performed a case-control study with consecutive primary APS patients divided into two groups, those who presented with IS, vs. those with no history of stroke. Demographics, vascular risk factors, therapeutic approaches, laboratory, imaging and functional outcomes were recorded. Fifty-three confirmed primary APS patients with IS and sixty-six non-stroke primary A
Like
Comment
Share
